Related Experiment Video
Updated: Mar 24, 2026

Assessment of the Metabolic Profile of Primary Leukemia Cells
Published on: November 21, 2018
Metabolic stressors disrupt proteome homeostasis to suppress malignancy
1The Jackson Laboratory, Bar Harbor, ME 04609, USA.
Abstract:
Within tumor cells the heat shock factor 1 (HSF1)-mediated stress response is constitutively mobilized to counter persistent proteotoxic stress, hence sustaining their fragile proteome homeostasis and supporting robust malignant phenotypes. Intriguingly, our new studies reveal that metabolic stressors, such as metformin, inactivate HSF1 and provoke proteomic chaos, thereby impeding tumorigenesis.
Insights
Metabolic stressors like metformin inactivate heat shock factor 1 (HSF1) in tumor cells. This disrupts proteome homeostasis, hindering cancer growth and offering a novel therapeutic strategy.
Area of Science:
- Cellular stress response
- Cancer biology
- Proteostasis mechanisms
Background:
- Tumor cells rely on the heat shock factor 1 (HSF1) stress response to maintain proteome homeostasis.
- Constitutive HSF1 activation supports malignant phenotypes and tumor survival.
- Persistent proteotoxic stress is a hallmark of cancer cells.
Purpose of the Study:
- To investigate the impact of metabolic stressors on HSF1 activity in cancer.
- To explore the potential of targeting HSF1 via metabolic interventions for cancer therapy.
- To elucidate the mechanisms by which metabolic stress affects proteomic stability in tumors.
Main Methods:
- Utilized cell culture models of cancer.
- Administered metabolic stressors, including metformin.
- Assessed HSF1 activity and downstream stress response markers.
- Analyzed proteomic profiles to evaluate cellular chaos.
Main Results:
- Metabolic stressors, exemplified by metformin, were found to inactivate HSF1.
- Inactivation of HSF1 led to significant proteomic chaos within tumor cells.
- Disruption of proteostasis by metformin impeded tumorigenesis.
- HSF1 inactivation represents a critical vulnerability in cancer cells.
Conclusions:
- Targeting HSF1 through metabolic interventions offers a promising strategy to combat cancer.
- Metformin and similar agents can disrupt cancer cell survival by destabilizing proteome homeostasis.
- Understanding the HSF1-mediated stress response is crucial for developing new anti-cancer therapies.
Related Concept Videos
Psychoneuroimmunology: Diabetes and Cancer
Abnormal Proliferation
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
Overview of Protein Metabolism
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
